findmyKOL
Clinical trialNCT06461026Active, not recruitingPhase 1Interventional

L9LS MAb in Malian Infants

SponsorNational Institute of Allergy and Infectious Diseases (NIAID)Enrollment180Malaria
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

  • Kassoum Kayentao, MD, MPH, PhD

    Faculté de Médecine Pharmacie d'Odontostomatologie (FMOS)

    Principal Investigator
  • Peter Crompton, MD, MPH

    National Institutes of Health (NIH)

    Principal Investigator

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

3 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Mali
  • Faladje Mrtc Clinic

    Faladié, Koulikoro, Mali

  • Kalifabougou Mrtc Clinic

    Kalifabougou, Koulikoro, Mali

  • Torodo Mrtc Clinic

    Torodo, Koulikoro, Mali

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
19 Aug 2024
Primary completion
27 Jun 2025
Completion
30 Jun 2026
Last update posted
25 Sept 2025
Registered enrollment
180
Registry id
NCT06461026

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.